Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer
European Journal of Nuclear Medicine and Molecular Imaging · 2024-06 · 51 (7) · 2070-2084
DOI: 10.1007/s00259-024-06648-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 20.02.2024. Verfasst von Jessica Pougoue Ketchemen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Trastuzumab, Erb-b2 Receptor Tyrosine Kinases, Copper Radioisotopes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Institute of Cancer Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada.
- Department of Pathology and Lab. Medicine, College of Medicine, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, SK, S7N 5A2, Canada.
- NURA Research Group, Belgian Nuclear Research Center (SCK CEN), Mol, Belgium.
- Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, Belgium.
- Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada. humphrey.fonge@usask.ca.
- Department of Medical Imaging, Royal University Hospital Saskatoon, Saskatoon, SK, S7N 0W8, Canada. humphrey.fonge@usask.ca.
ORCID-Profile: Humphrey Fonge
Förderung
- Institute of Cancer Research
Zitieren
APA
Pougoue Ketchemen, J., Njotu, F. N., Babeker, H., Ahenkorah, S., Tikum, A. F., Nwangele, E., Henning, N., Cleeren, F., & Fonge, H. (2024). Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging, 51(7), 2070-2084. https://doi.org/10.1007/s00259-024-06648-3
Vancouver
Pougoue Ketchemen J, Njotu FN, Babeker H, Ahenkorah S, Tikum AF, Nwangele E, et al. Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(7):2070-2084. doi:10.1007/s00259-024-06648-3
BibTeX
@article{PougoueKetchemen2024,
author = {Pougoue Ketchemen, Jessica and Njotu, Fabrice Ngoh and Babeker, Hanan and Ahenkorah, Stephen and Tikum, Anjong Florence and Nwangele, Emmanuel and Henning, Nikita and Cleeren, Frederik and Fonge, Humphrey},
title = {Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
volume = {51},
number = {7},
pages = {2070--2084},
doi = {10.1007/s00259-024-06648-3}
}
EUVIMED